Multiple injuries in 2017 prevented David Price from passing the 100 IP mark for the first time in his career—what can his skills tell us about his outlook for 2018? Plus, Grandal, Beltre, Edwards and L. Garcia.

There are a lot of relievers to choose from in the end game. Here are some superior skill sets that should be available.

Could Ryan Braun’s injury-riddled 2017 present a buying opportunity? Plus, Brandon Morrow, Aaron Altherr, Ivan Nova, and Tyler Flowers.

Mark Leiter is one of many low-producing pitchers from 2017 who could deliver some surprising profit in 2018.

A.J. Pollock missed a significant amount of time due to injury again in 2017, but was a force when he was on the field. More on his outlook for 2018, plus Todd Frazier, Brandon Crawford, Rich Hill, and Tyler Anderson.

Whit Merrifield attempts to follow up breakout season, Mikie Mahtook looks to make the most of his playing time, Edwin Diaz holds down the ninth inning, and Nomar Mazara's skills are stuck in neutral.

Dylan Bundy has taken us on a roller coaster. Should you buy a ticket? Plus: Robinson Chirnos, Danny Duffy, Ian Kinsler, and Rougned Odor.

Michael Taylor is one of several young bats in each league whose multi-category production is at risk due to big plate discipline warts.

Anthony Rendon rang up career highs in batting average, HR, and RBI in 2017—do his skills give us any idea whether he can do it again in 2018? Plus, Brad Brach, Johnny Cueto, Salvador Perez, and Jameson Taillon.

This column looks at some risky closer situations—buyer beware on these gambles.

Relievers are good for more than saves! But it's mostly about the saves!